Turing Biosystems Company
Turing Biosystems concentrates on the problems of severe toxicities and elevated failure rates in immunotherapy, cell, and gene therapy. The platform is based on a revolutionary interpretable AI that uses automated reasoning and current technology. Their platform integrates all accessible multimodal data and details on a patient or cohort, including metadata, medical records, and other data.
Industry:
BioPharma AI
Technology:
Predictive Toxicology and ADMET Modeling
Headquarters:
London,England,United Kingdom,Europe
Funding Status:
private
Founded Date:
2020-01-01 00:00:00


